$BGT News

BGT: The 13% Dividend Yield Is Not Supported By Earnings

BGT: Earnings Unlikely To Improve As Long As Interest Rates Are High (Rating Downgrade)

BGT: Little Chance Of Outsized Returns, But Risks Are Manageable

BGT: Floating Rate Loans CEF Under Pressure

BGT: The Golden Era For Floating Rate Funds Have Passed

PHD: Recent Events Point To Poor Returns Going Forward

BGT: Failing To Cover Distributions And Unlikely To Improve (Rating Downgrade)

BGT: Solid Returns But High Fees And High Volatility

EFT: Forward Performance Will Likely Disappoint Due To Rate Cuts

Bio-Gene Technology Strengthens Market Position with Flavocide Progress

Bio-Gene Technology Announces Hybrid AGM for 2024

Notable Two Hundred Day Moving Average Cross - BGT

Bio-Gene Unveils Strategy in Investor Briefing

VVR: This Fund Is Overpriced For The Current Monetary Conditions (Rating Downgrade)

BlackRock Floating Rate Income Trust Fund declares $0.1202 dividend

BlackRock Floating Rate Income Trust Fund declares $0.1203 dividend

Bio-Gene’s Breakthrough in Flavocide Production

J.P. Morgan Reaffirms Their Buy Rating on Bridgestone (BRDCF)

Bio-Gene Technology Updates Corporate Governance

Bio-Gene Reports Revenue Drop and Lower Losses